You are here

Article metrics

Article menu

Download PDFPDF

Inflammatory Bowel Disease
Orals
OWE-05 Interim long-term safety/efficacy of risankizumab treatment in crohn’s disease patients from the open-label extension study
Free

 

Online download statistics by month:

Online download statistics by month: June 2019 to April 2023

AbstractFullPdf
Jun 20193308
Jul 20192304
Aug 20192304
Sep 20193609
Oct 201959010
Nov 201979010
Dec 20194207
Jan 20208508
Feb 202015309
Mar 2020129016
Apr 202012009
May 20208803
Jun 20208406
Jul 20208207
Aug 20204304
Sep 2020300016
Oct 202095010
Nov 202075013
Dec 20206007
Jan 20217606
Feb 20212706
Mar 20212507
Apr 20213204
May 20212104
Jun 2021004
Aug 2021005
Sep 2021205
Oct 20211800
Nov 20213008
Dec 20214301
Jan 20222206
Feb 20223202
Mar 20223102
Apr 20223006
May 202235012
Jun 20222706
Jul 20227204
Aug 20221702
Sep 20221203
Oct 20223008
Nov 20221306
Dec 20221001
Jan 20235503
Feb 20233401
Mar 20231100
Apr 20232000
Total23340272